Juste R N, Panikkar K, Soni N
Magill Department of Anaesthesia, Chelsea and Westminster Hospital, London, UK.
Intensive Care Med. 1998 Jun;24(6):564-8. doi: 10.1007/s001340050616.
To investigate whether low-dose dopamine (LDD) has a significant effect on systemic haemodynamic variables and renal function when used in conjunction with high-dose noradrenaline in optimally volume-resuscitated patients with septic shock.
A prospective clinical study in which each patient acted as his/her own control.
Teaching hospital Intensive Care Unit.
Twenty-one patients with septic shock treated with high-dose noradrenaline were studied, 17 patients completed the study.
Fluid loading to an optimal left ventricular stroke work index (LVSWI) whilst on more noradrenaline than 10 mcg/min and dopamine of 2.5 mcg/kg per min. Three study periods each of 2 h with LDD present, withdrawn and restarted. During each period a complete haemodynamic profile and measurement of urine flow rate, creatinine clearance and sodium excretion was performed.
Removing and restarting LDD caused marked changes in cardiac index (CI, 17% fall, p < 0.01: 23% rise, p < 0.01), stroke volume (SV, 11% fall, p < 0.05: 14% rise, p < 0.05) and systolic blood pressure (SBP, 11% fall, p < 0.05: 14% rise, p < 0.05). Urine volume fell by 40% (p < 0.05) when dopamine was withdrawn. Significant reductions in sodium excretion (p < 0.05) and fractional sodium excretion (p < 0.05) also occurred on stopping LLD. Changes in creatinine clearance were not statistically significant.
Low-dose dopamine causes significant increases in SBP SV, cardiac output and urine flow during treatment with noradrenaline.
研究在液体复苏充分的感染性休克患者中,小剂量多巴胺(LDD)与大剂量去甲肾上腺素联用时,对全身血流动力学参数和肾功能是否有显著影响。
一项前瞻性临床研究,每位患者均作为自身对照。
教学医院重症监护病房。
21例接受大剂量去甲肾上腺素治疗的感染性休克患者,17例完成研究。
在去甲肾上腺素用量超过10微克/分钟且多巴胺用量为2.5微克/千克每分钟的情况下,进行液体负荷以达到最佳左心室每搏功指数(LVSWI)。研究分为三个阶段,每个阶段2小时,分别为使用LDD、停用LDD和重新使用LDD。在每个阶段,均进行完整的血流动力学评估,并测量尿流率、肌酐清除率和钠排泄量。
停用和重新使用LDD导致心脏指数(CI,下降17%,p<0.01;上升23%,p<0.01)、每搏量(SV,下降11%,p<0.05;上升14%,p<0.05)和收缩压(SBP,下降11%,p<0.05;上升14%,p<0.05)出现显著变化。停用多巴胺后,尿量下降40%(p<0.05)。停用LDD时,钠排泄量(p<0.05)和钠排泄分数(p<0.05)也显著降低。肌酐清除率的变化无统计学意义。
在使用去甲肾上腺素治疗期间,小剂量多巴胺可显著提高SBP、SV、心输出量和尿量。